June 21, 2005 HOT TOPICS NEWS & INFORMATION: TOOLS FOR: RESOURCES:  >  > Attention Business Editors: CryoCath's U.S. Trial for Atrial Fibrillation Underway - First patient successfully treated at Mayo Clinic - Toronto Stock Exchange Symbol: CYT www.cryocath.com MONTREAL, June 15 /CNW/ - CryoCath Technologies Inc., the global leader in cryotherapy products to treat cardiovascular disease, today announced the first patient was treated in its Cryo System Trial Of Paroxysmal Atrial Fibrillation (STOP AF), an Investigational Device Exemption (IDE) trial using its proprietary Arctic Front(TM) catheter for Atrial Fibrillation (AF). Dr. Douglas Packer, from Mayo Clinic, Rochester, Minnesota, and the principal investigator of this study, performed the procedure. The procedure resulted in an acute success, with all four pulmonary veins electrically

more...